PFE Jan 2025 57.500 put
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:29PM EDT. Market open.
Loading interactive chart…
- Yahoo Finance
Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
Competition is heating up in the GLP-1 space as Amgen gets closer to the finish line with its candidate.
- GuruFocus.com
Vanguard Health Care Fund's Strategic Moves in Q1 2024: A Focus on Pfizer Inc
Insight into the Fund's Latest Investment Decisions and Stock Adjustments
- Zacks
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Eli Lilly (LLY), Novo Nordisk (NVO), Pfizer (PFE) and AbbVie (ABBV) announce their first-quarter results.
© 2024 Yahoo. All rights reserved.